Skip to main content

CORRECTION article

Front. Cardiovasc. Med. , 13 May 2022

Sec. Cardio-Oncology

Volume 9 - 2022 | https://doi.org/10.3389/fcvm.2022.903766

This article is part of the Research Topic Women in Cardio-Oncology View all 17 articles

Corrigendum: Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story

This article is a correction to:

  1. Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story

    1. Read original article
\nIrma BiscegliaIrma Bisceglia1Maria Laura CanaleMaria Laura Canale2Giuseppina Gallucci Giuseppina Gallucci3*Fabio Maria TurazzaFabio Maria Turazza4Chiara LestuzziChiara Lestuzzi5Iris ParriniIris Parrini6Giulia RussoGiulia Russo7Nicola MaureaNicola Maurea8Vincenzo QuagliarielloVincenzo Quagliariello9Stefano OlivaStefano Oliva10Stefania Angela Di FuscoStefania Angela Di Fusco11Fabiana LucFabiana Lucà12Luigi TarantiniLuigi Tarantini13Paolo TrambaioloPaolo Trambaiolo14Antonella MoreoAntonella Moreo15Giovanna GeraciGiovanna Geraci16Domenico GabrielliDomenico Gabrielli17Michele Massimo GuliziaMichele Massimo Gulizia18Fabrizio OlivaFabrizio Oliva19Furio ColivicchiFurio Colivicchi11
  • 1Integrated Cardiology Services, Cardio-Thoracic-Vascular Department, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy
  • 2Cardiology Department, Nuovo Ospedale Versilia Lido di Camaiore Lucca, Camaiore, Italy
  • 3Cardio-Oncology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Referral Cancer Center of Basilicata, Rionero in Vulture, Italy
  • 4Cardiology Department, National Cancer Institute Foundation, Milan, Italy
  • 5Azienda Sanitaria Friuli Occidentale (ASFO) Cardiac and Cardio-Oncologic Rehabilitation Service at Centro di Riferimento Oncologico (CRO), National Cancer Institute, Aviano, Italy
  • 6Cardiology Department, Ospedale Mauriziano Umberto I, Turin, Italy
  • 7Cardiovascular and Sports Medicine Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) Trieste, Trieste, Italy
  • 8Cardiology Department, G. Pascale National Cancer Institute Foundation (IRCCS), Naples, Italy
  • 9Cardiology Department, G. Pascale National Cancer Institute Foundation (IRCCS), Naples, Italy
  • 10Cardio-Oncology Department, Istituto Tumori Giovanni Paolo II, Bari, Italy
  • 11Clinical and Rehabilitation Cardiology Department, Ospedale San Filippo Neri, Rome, Italy
  • 12Cardiology Department, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy
  • 13Divisione di Cardiologia, Arcispedale S. Maria Nuova, Azienda Unità Sanitaria Locale-IRCCS di Reggio-Emilia, Reggio Emilia, Italy
  • 14Cardiology Department, Sandro Pertini Hospital, Rome, Italy
  • 15A. De Gasperis Cardio Center, Aziende Socio Sanitarie Territoriali (ASST) Grande Ospedale Metropolitano Niguarda, Milan, Italy
  • 16Cardiology Unit, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
  • 17Cardio-Thoracic-Vascular Department, San Camillo-Forlanini Hospital, Rome, Italy
  • 18Cardiology Department, Garibaldi Hospital, Catania, Italy
  • 19Dipartimento Cardiotoracovascolare, Cardiology 1-Cath Lab, Coronary Care Unit (CCU), ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy

A Corrigendum on
Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story

by Bisceglia, I., Canale, M. L., Gallucci, G., Turazza, F. M., Lestuzzi, C., Parrini, I., Russo, G., Maurea, N., Quagliariello, V., Oliva, S., Di Fusco, S. A., Lucà, F., Tarantini, L., Trambaiolo, P., Moreo, A., Geraci, G., Gabrielli, D., Gulizia, M. M., Oliva, F., and Colivicchi, F. (2022). Front. Cardiovasc. Med. 9:821193. doi: 10.3389/fcvm.2022.821193

In the published article, there was an error in affiliation 13. Instead of “Cardiology Department, Santa Maria Nuova Hospital, Reggio Emilia, Italy,” it should be “Divisione di Cardiologia, Arcispedale S. Maria Nuova, Azienda Unità Sanitaria Locale-IRCCS di Reggio-Emilia, Reggio Emilia, Italy.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: SARS-CoV-2, COVID-19, cancer, cardiovascular disease, cardiotoxicity, syndemic, telehealth

Citation: Bisceglia I, Canale ML, Gallucci G, Turazza FM, Lestuzzi C, Parrini I, Russo G, Maurea N, Quagliariello V, Oliva S, Di Fusco SA, Lucà F, Tarantini L, Trambaiolo P, Moreo A, Geraci G, Gabrielli D, Gulizia MM, Oliva F and Colivicchi F (2022) Corrigendum: Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story. Front. Cardiovasc. Med. 9:903766. doi: 10.3389/fcvm.2022.903766

Received: 24 March 2022; Accepted: 27 April 2022;
Published: 13 May 2022.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Bisceglia, Canale, Gallucci, Turazza, Lestuzzi, Parrini, Russo, Maurea, Quagliariello, Oliva, Di Fusco, Lucà, Tarantini, Trambaiolo, Moreo, Geraci, Gabrielli, Gulizia, Oliva and Colivicchi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Giuseppina Gallucci, cGluYS5nYWxsdWNjaUB0aXNjYWxpLml0

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

Man ultramarathon runner in the mountains he trains at sunset

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more